CLART® is a low density microarray-based platform for clinical use that allows the detection of multiple targets in a single test. Sample processing is straightforward and the analysis and interpretation of results are performed automatically by a reader (CAR® or CLINICAL ARRAY READER) running tailor-made software. Its simplicity makes this technology suitable for every molecular diagnostics laboratory.
CLART® provides fast, sensitive and accurate results that meet the highest quality standards, and allows the clinician to take the right decisions on time.
CLART is divided in Microbiology kits for diverse pathogenes detection and an Oncology line named CLART CMA to detect mutations in oncogenes.
GENOMICA is the first Spanish company in Molecular Diagnostics that develops and manufactures CLART, its own line of IVD kits. The company is currently commercializing them in more than 40 countries worldwide and dispose of subsidiaries offices in China, Brazil, and Sweden. The company is a reference globally as a reliable and competitive kits supplier. Its kits are used in screening programs under its own brand. Also, it has OEM agreements with international brands.
GENOMICA is committed to the highest quality standards and put a huge effort into research and development. The company is now working in a breakthroug development: NEDxA, its very first POCT device.